Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 28, 2017
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation studyArchana Rastogi, Saggere Muralikrishna Shasthry, Ayushi Agarwal, et al.Frontiers in Physiology|June 7, 2018
Circulating Endothelial Progenitor Cells Present an Inflammatory Phenotype and Function in Patients With Alcoholic Liver CirrhosisSavneet Kaur, Rashi Sehgal, Saggere M Shastry, et al.Pediatric Transplantation|November 14, 2006
Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertensionBenjamin Shneider, Sukru Emre, Roberto Groszmann, et al.Research Square|June 5, 2026
Ahead, a Novel Validated Machine Learning Model for Clinical Diagnosis of Alcohol Associated HepatitisDavid Malicote, Gene Im, Ethan Weinberg, et al.Hepatology (Baltimore, Md.)|May 26, 2017
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysisAgustín Albillos, Javier Zamora, Javier Martínez, et al.Frontiers in Cell and Developmental Biology|August 2, 2021
The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ InjuryUgo Soffientini, Nigel Beaton, Sukriti Baweja, et al.Hepatology (Baltimore, Md.)|July 5, 2019
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR TrialsQuentin M Anstee, Eric J Lawitz, Naim Alkhouri, et al.Journal of Hepatology|March 10, 2020
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trialsStephen A Harrison, Vincent Wai-Sun Wong, Takeshi Okanoue, et al.The Lancet. Gastroenterology & Hepatology|July 12, 2024
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studiesLaure Elkrief, Virginia Hernandez-Gea, Marco Senzolo, et al.Pageof 2